Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT05672576

Public ClinicalTrials.gov record NCT05672576. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of Cenerimod in Adult Subjects With Moderate-to-severe Systemic Lupus Erythematosus (SLE) on Top of Background Therapy

Study identification

NCT ID
NCT05672576
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Viatris Innovation GmbH
Industry
Enrollment
451 participants

Conditions and interventions

Interventions

  • Cenerimod Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 25, 2023
Primary completion
Oct 30, 2026
Completion
Apr 30, 2027
Last update posted
Jul 13, 2026

2023 – 2027

United States locations

U.S. sites
17
U.S. states
7
U.S. cities
15
Facility City State ZIP Site status
Tucson Clinical Research Institute, LLC Tucson Arizona 85712
UCSD Perlman Medical Offices La Jolla California 92037-0943
Amicis Research Center Northridge California 91234
Hope Clinical Trials, Inc. Coral Gables Florida 33134
Vital Pharma Research Hialeah Florida 33016
Tectum Medical Research Hollywood Florida 33024
Alloy Clinical Research, LLC Kissimmee Florida 34741
Allied Biomedical Research Institute Miami Florida 33155
D&H National Research Centers INC Miami Florida 33155
Professional research Center INC Miami Florida 33172
San Marcus Research Clinic, Inc. Miami Lakes Florida 33014
Tandem Clinical Research Marrero Louisiana 70072
RB Wellness Clinic Las Vegas Nevada 89102
Columbia University Medical Center New York New York 10032
Precision Comprehensive Clinical Research Solutions Colleyville Texas 76034
Texas Arthritis Center El Paso Texas 79902
Northwest Houston Arthritis Center Houston Texas 77090

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 130 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05672576, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 13, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05672576 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →